Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
49.7M
-
Shares change
-
+2.51M
-
Total reported value, excl. options
-
$345M
-
Value change
-
+$16M
-
Put/Call ratio
-
1.01
-
Number of buys
-
48
-
Number of sells
-
-35
-
Price
-
$6.95
Significant Holders of LION BIOTECHNOLOGIES INC - COM (LBIO) as of Q4 2016
110 filings reported holding LBIO - LION BIOTECHNOLOGIES INC - COM as of Q4 2016.
LION BIOTECHNOLOGIES INC - COM (LBIO) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.7M shares
.
Largest 10 shareholders include FRANKLIN RESOURCES INC (5.21M shares), venBio Select Advisor LLC (4.52M shares), FMR LLC (4.47M shares), ACUTA CAPITAL PARTNERS, LLC (3.81M shares), PERCEPTIVE ADVISORS LLC (3.57M shares), ORBIMED ADVISORS LLC (3.38M shares), BlackRock Fund Advisors (2.67M shares), Broadfin Capital, LLC (2.64M shares), VICTORY CAPITAL MANAGEMENT INC (2.34M shares), and VANGUARD GROUP INC (2.22M shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.